CAR T-cell therapies in treating lymphoma: Pros and cons – ModernMedicine
|
CAR T-cell therapies in treating lymphoma: Pros and cons
ModernMedicine Catherine Bollard, MD, director of the Center for Cancer and Immunology Research at Washington, D.C.-based Children's National Health System, discussed immunotherapy for non-Hodgkin's lymphoma at the 2017 American Society of Hematology (ASH) annual … |
